Renub Research

Cardiac Maker Analyzer – Product Analysis, Business & Marketing Strategy

Press Release   •   Aug 14, 2017 03:11 EDT

Download full Report: http://www.renub.com/cardiac-maker-analyzer-product-analysis-business-and-marketing-strategy-of-cardiac-maker-companies-1180-p.php

Get 10% Free Customization in this Report

Cardiac Maker Analyzer – Product Analysis

Cardiometabolic products and services provide timely cardiovascular and metabolic information at the point-of-care. Until today, Troponin and CK-MB were the lead cardiac markers. Brain Natriuetic Pepetide (BNP) was recently introduced to differentiate between a Myocardial Infarction and Heart Failure. The routine markers of myocardial infarction – CK-MB, Troponin and Myoglobin and recently BNP are used in the acute care and tests such as Cholesterol are used to evaluate risk. A number of companies are focused on developing new cardiac markers.

Alere delivers reliable and actionable health information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally. Alere’s Cardiology net product sale was more than US$ 600 Million in 2016 and is expected to rule this industry in the future.

Beckman Coulter offers the maximum number of cardiac marker tests on its cardiology platform while Abbott Laboratories (i-Stat) and Siemens Healthineers (Stratus® CS Analyzer) also perform several cardiac marker tests on their cardio-metabolism platform and establishes them as the leader in this market.

Cardiac Markers Analyzers usually measure the levels of enzymes and proteins released from heart muscle when it is damaged. Physicians use cardiac markers in two ways – to diagnose a cardiac event in a hospital emergency room or within the hospital or to evaluate a risk of a cardiovascular event occurring.

Cardiac Maker Analyzer – Product Analysis, Business & Marketing Strategy of Cardiac Maker Companies is the 2nd report published by Renub Research. This 105 page report contains 14 Figures and 12 Tables provides a comprehensive analysis of the cardiac markers analyzer segments, including their comparative tests analysis, competitive product analysis, product features, merger, acquisitions, analyzer sales figures and Business and Market Strategies of Companies.

All the 12 Cardiac Marker Analyzers in the report have been studied from 5 viewpoints.
1. Analyzer Specifications and Benefits
2. Net Product Sales
3. Merger, Acquisition & Licensing Agreement
4. Marketing Strategies
5. Methods of Distribution

The 12 Cardiac Marker Analyzer studied in the report are as follows:
1. Alere Meterpro Analyzer
2. RAMP 200
3. RAMP Reader
4. The i–STAT System
5. Cobas h 232 POC System
6. Stratus CS Analyzer
7. Access 2 Immunoassay System
8. ichroma DUO Analyzer
9. DXpress Reader Analyzer
10. PATHFAST Analyzer
11. Meritas POC Analyzer
12. QL Care Analyzer

Contact Us

Rajat Gupta

Sr. Marketing Manager

Email: info@renub.com

Phone: +1-678-302-0700

Web: www.renub.com

Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets.